Navigation Links
Elsevier Welcomes New Editor-in-Chief for European Urology
Date:1/28/2013

AMSTERDAM, The Netherlands, January 28, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, welcomes Dr. James Catto, MB ChB, PhD, FRCS (Urol), of the Academic Urology Unit, Royal Hallamshire Hospital in Sheffield (UK) as the new Editor-in-Chief of European Urology, the official journal of the European Association of Urology (EAU).

The journal has been a prestigious urological forum for over 35 years, and is currently read by more than 20,000 urologists across the globe. With an impact factor of 8.493, European Urology is now the leading scientific publication in the field of urology. Dr. Catto will replace Professor Montorsi effective January 1, 2014.

In his new role, Dr. Catto aims to strengthen the journal's success and envisions European Urology as a high quality and high impact journal which is supported by a robust multimedia platform and a user-friendly interface.

"We will expand into social media platforms and create a more interactive user experience. I will try to broaden our appeal to other professionals, but at our core we will remain a high quality urological journal that serves and highly values its readers and authors," explained Dr. Catto. "European Urology greatly contributes to the mission of the EAU - improving the care for patients with urological disease - and this is a tremendous motivation for me. As Editor-in-Chief, I will be able to focus the minds of our readership upon crucial clinical issues, whilst driving forward change and innovation. I aim to keep urologists at the forefront of clinical developments and make them key to high quality patient care."

"I am thankful to work with the EAU and also very grateful for its support and input over the last years. I look forward to working with the newly appointed Editor-in-Chief, Dr. James Catto and his editorial team. The management and cure of for instance prostate cancer as well as the advanced search for the basic mechanisms of urologic diseases are major and global challenges of the 21st century. Elsevier is confident to make European Urology a continuing and growing success for authors, readers and for the EAU," commented Koos Admiraal MD, Executive Publisher for Elsevier.

About European Urology
European Urology, the official journal of the EAU, has been a prestigious urological forum for over 35 years, and is currently read by more than 20,000 urologists across the globe. With an impact factor of 8.493, the journal is now the leading scientific publication in the field of urology. For more information, go to: http://www.europeanurology.com

About the European Association of Urology
The European Association of Urology (EAU) is a non-profit organisation which supports medical professionals working in the field of urology through many of its scientific, professional, educational and awareness-building initiatives. Through its work the EAU aims to raise the level of urological care in Europe. For more information about the EAU, go to: http://www.uroweb.org

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Carolien van der Zanden
Elsevier
+31-20-485-3346
c.zanden@elsevier.com



'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
2. Elsevier and the Dutch Fulbright Center Start Collaboration to Support Early Career Researchers in the Netherlands
3. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
4. Elsevier Acquires ExitCare, Provider of Patient Education Solutions
5. Elsevier Collaborates With Infocomm Development Authority of Singapore and Top Academic Institutions to Bring CodeForScience to Singapore
6. Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology
7. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
8. Elsevier Launches New Journal: Performance Enhancement & Health
9. Elsevier Expands Access to Digital Offerings Through Collaboration with Follett
10. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
11. Society of Biological Psychiatry and Elsevier Renew Publishing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
Breaking Biology News(10 mins):